Members: Premium Members

Argenta Reimbursement Advisors provides strategically integrated reimbursement solutions to life science companies. Argenta’s focus is to deliver actionable strategic reimbursement counsel in order to work in concert with achieving the client’s business objectives. The Argenta team has the unique ability to leverage its expertise along the full continuum from strategy formation and coding and payment systems analysis to payer negotiations and customer reimbursement support. This means that Argenta can be a single-source solution for addressing the unique and often complex reimbursement needs of companies in the medical device industry.

10% premium credit*

For more than 25 years, member insurers of the Chubb Group of Insurance Companies ("Chubb") have been providing cost-effective risk management and insurance protection tailored to the unique requirements of medical device companies. Chubb's insurance professionals specialize in the medical device market; they understand the issues and develop solutions for unique insurance needs. This experience and expertise, coupled with Chubb's financial strength and superior claims service, were the reasons MDMA selected Chubb as its preferred insurer for Property, Package, Clinical Trials Liability, Errors and Omissions Liability Insurance, Products Liability & Professional Liability Insurance.

The insurance offered by Chubb is:

• Clinical Trials and Product Liability: Insurance for commercialized products as well as products in all stages of human clinical trials.
• Errors and Omissions Liability Insurance: Insurance for financial loss to third parties arising out of negligence.
• Professional Liability: Insurance for companies conducting contract research.

Member Benefits

Medical Device Manufacturers Association (MDMA) Member Benefit:

• 10% premium credit (*subject to our rates and rules and regulatory limitations)
• Competitive premiums for companies at all stages
• Low minimum premiums for early stage companies
• Broad insurance to meet the unique needs of the medical device industry

More Information

More information about Chubb's capabilities in serving the Life Sciences industries can be found at www.chubb.com/mdma
To learn about specific details about the program, including coverages and premium rates, contact a Chubb appointed insurance agent or broker.

Chubb Group of Insurance Companies is a marketing name used to refer to the insurance subsidiaries of The Chubb Corporation. For a list of these subsidiaries and general information, please visit our website at www.chubb.com/mdma. Actual coverage is subject to the language of the policies as issued. Chubb, Box 1615, Warren, NJ 07061-1615.

Dymedex Consulting is the thought leader in med-tech market analysis. Eight out of ten med-tech ventures fail to deliver significant returns to investors, despite experienced leadership and sufficient capital. Good decisions aren't possible when based on bad information. Dymedex delivers the reliable foundation of fact-based market insights that executives need to inform core strategies and key investments. In today's economy, there may be just one chance to get it right. From start-ups to large enterprises, we provide confidence for strategic decisions by deconstructing your technology adoption curve and quantifying the key elements that will accelerate commercial success.

Fasken Martineau is a full-service international law firm with offices in all major cities in Canada, as well as London, Paris and Johannesburg. Our Life Sciences team (comprising regulatory, licensing,  IP protection and litigation, outsourcing, corporate, corporate financing and tax practitioners) works with businesses across the life sciences spectrum at various stages of growth. Our clients include medical devices companies, multinational and specialty pharmaceutical businesses, and biotechnology companies.  Our medical devices team has earned international recognition, and has strong technical capabilities in all medical disciplines as well as extensive experience in all aspects of medical devices regulation in Canada and Europe.

With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world practicing all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan has delivered successful, sophisticated legal strategies to help medical device clients protect, advocate, and leverage their valuable IP assets.   Our clients are involved in diverse medical technologies, such as interventional cardiology, endoscopic surgery, diabetes management, and diagnostic tools and methods that allow for earlier detection of diseases and less invasive drug-delivery methods. For more information, please visit www.finnegan.com.

With over $17 billion invested, GE Capital, Healthcare Financial Services is a premier provider of capital and services to the healthcare industry, with investments in more than 40 sub-sectors including senior housing, hospitals, pharmaceuticals, and medical devices. Our team of professionals provides deep industry expertise to create business and financial solutions tailored to meet the individual needs of our customers.  For more information, visit www.gecapital.com/healthcare

Hull Associates is a global government affairs and reimbursement consultancy, focused on medical device and diagnostics issues in the major markets outside of the United States. We specialize in managing the relationships that are critical to successful implementation of reimbursement and market access strategies. We focus with our clients on building their capabilities to manage and execute solid international reimbursement strategies. Hull Associates successfully manages all dimensions of reimbursement, from understanding the technical aspects of payment systems to leveraging maximum political advantage of key stakeholder interests. Our firm delivers fully integrated support to maximize market outcomes for medical device clients, from dossier preparation to sales force trainings and coalition building. Seasoned medical device consultants in all major markets of the Globe. Providing reimbursement analysis, market forecasting, pricing studies and lobbying support in all the major markets.

The medical device industry in Georgia is thriving, bolstered by the presence of outstanding educational and research resources. The joint program between Emory University and the Georgia Institute of Technology has been ranked #2 nationally in biomedical engineering degree programs.

The Metro Atlanta Chamber has determined that there are over 200 companies and organizations focusing on the research, development, commercialization or manufacturing of products used for medical purposes in patients, in diagnosis, therapy or surgery.

From industry pioneers like C.R. Bard and Stryker to innovative start-ups like CardioMEMS and Given Imaging, metro Atlanta has a wide range of medical devices companies.

For more information about Atlanta's Bioscience and Health IT industry contact:  David Hartnett at: 404-586-8433 or by email at dhartnett@macoc.com or visit us at www.bioscience.metroatlantachamber.com.

NAMSA is medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. At every stage of the product development process, NAMSA provides strategic guidance and tactical support to help clients commercialize medical products in the major markets of the world.

NAMSA serve's as your trusted partner, using insight to identify strategies for saving time, while never compromising quality. NAMSA knows that compromised quality can quickly take your product right back to the starting line. That's why it's so important to have a smart strategy from the outset-and why NAMSA puts it at the forefront of every project.

The path to regulatory approval can be long and complex. NAMSA provides a reliable way to get there.

NeuvoMedica is a Market Development firm focused on the China Medical Device Market.  We work with Medical Technology companies to commercialize new products and maximize the market potential for new and existing products.  We act as a fully integrated operation for medical device and equipment companies seeking to succeed in China by providing market analysis, strategic planning, product registration, and professional sales and distribution services.

Combining international management techniques along with a deep understanding of the business and cultural practices of China, we help clients develop a professional, transparent and disciplined approach to the commercialization and sales of medical technology in China.

NeuvoMedica has also prepared a white paper on entering the Chinese Market exclusively available to MDMA members.  

Pacific Bridge Medical (PBM) is a leading medical consulting firm dedicated to assisting medical companies in Asia. Our consultants have helped hundreds of medical companies with business development and regulatory affairs in Asia since our founding in 1988. Our services include registering medical products, finding distributors, sourcing/manufacturing, setting up joint ventures, conducting market research, and more. We can help you in China, India, Japan, Korea, Taiwan, and other Asian countries. We also host monthly Asia medical webcasts and publish updated medical reports available for sale. We publish a FREE monthly Asian Medical eNewsletter. Please see our website at www.pacificbridgemedical.com to subscribe.

R-Squared Services & Solutions, Inc. (R-Sqaured = Risk Reduction) is a software company that helps life science companies develop more efficient and effective ways to assure compliance with the web of regulations and laws affecting the organization. Our off the shelf solutions include key areas like Physician contracting, spend analysis and grants funding. We are especially good at translating regulatory requirements into workable tools and practices that simplify the task of abiding by regulations - while generating solid evidence of compliance at the same time. We're about tighter compliance, with fewer burdens. R-Squared is uniquely qualified to provide these services because of the vast depth of internal subject matter expertise starting with its CEO, Mike Bell, Esq. and it's team of health care attorney's and former compliance officers actively involved in the functional development and implementation of the entire suite of compliance solutions.

Split Rock Partners invests in emerging healthcare, software and Internet services companies in the Upper Midwest and West Coast. We are an early-stage venture capital firm that was founded in June 2004 by the former healthcare and software investment teams of St. Paul Venture Capital (SPVC). The Split Rock team managed over $1 billion of venture capital during our tenure at SPVC, and continues to manage the SPVC healthcare and software portfolio. In May of 2008, we raised $300 million in our second Split Rock Partners fund, the successor to our inaugural $275 million fund raised in April 2005.

Strathspey Crown LLC is a strategically positioned growth equity firm that partners with physicians to foster the development of innovative healthcare technologies, therapies, procedures, and services. However, new barriers are being created as governments throughout the world continue to aggressively regulate the reactive/reimbursement healthcare sector. Barriers that severely limit consumer choice. Barriers that dramatically impede the innovation and growth of medical technologies and services. Which is why Strathspey Crown specializes in identifying and supporting emerging opportunities in the proactive/private-pay healthcare sector that offer compelling new medical wellness and/or "lifestyle" benefits.